Tata's Cancer Prevention Drug Breakthrough

The Tata Institute in Mumbai revealed the creation of a groundbreaking drug to deter cancer recurrence. After a decade of research, the institute's team developed a tablet purported to halt secondary cancer occurrences. Priced at ₹100 each, the tablet's efficacy was demonstrated through experiments on mice, prompting forthcoming human trials. Dr. Indraneel Mittra, leading the study at TMH, highlighted promising results.